Death in CRISPR gene therapy study sparks search for answers
medicalxpress.com
medicalxpress.com
"The U.S. Food and Drug Administration (FDA) has given the go-ahead for the first-in-human dosing of Cure Rare Disease’s (CRD) investigational genome-editing therapeutic for Duchenne muscular dystrophy (DMD).
"Dosing of a single patient with the treatment, dubbed CRD-TMH-001, will happen soon at the University of Massachusetts Chan Medical School."
https://musculardystrophynews.com/news/crd-gene-editing-ther...
Maybe they got killed in a school shooting and it's used to cast doubt on this treatment? Absurd to write the headline and publish the article before making the connection.
https://www.cureraredisease.org/blog-posts/to-our-community-...